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INTERLEUKIN-1-INDUCED COX-2 AND INOS EXPRESSION IN OA HUMAN
CHONDROCYTES IS ASSOCIATEDWITH HISTONE H3K4 METHYLATION
F. El Mansouri, N. Chabane, N. Zayed, J. Martel-Pelletier, J.-P. Pelletier,
h. Fahmi
Montreal Univ., Montreal, QC, Canada
Purpose: Increased expression of inducible NO synthase (iNOS) and cy-
clooxygenase (COX)-2 plays a key role in the pathogenesis of osteoarthritis
(OA). Methylation of lysine 4 on histone H3 (H3K4) was shown to be of fun-
damental importance in the regulation of gene expression. In the present
study, we investigated the role of H3K4 methylation in interleukin-1β
(IL-1)-induced COX-2 and iNOS expression in human OA chondrocytes
Methods: Chondrocytes were stimulated with IL-1 for various time periods
and the expression of iNOS and COX-2 mRNAs and proteins were evaluated
using real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
and Western blotting, respectively. H3K4 methylation at the iNOS and
COX-2 promoters was evaluated using chromatin immunoprecipitation
(ChIP) assays. The role of histone methylation was further evaluated using
the methyltransferase inhibitor, 5’-deoxy-5’(methylthio) adenosine (MTA).
Results: IL-1 induced iNOS and COX-2 mRNA and protein in a dose- and
time-dependent manner. The induction of iNOS and COX-2 expression by
IL-1 was associated with H3K4 di- and trimethylation at the iNOS and
COX-2 promoters, whereas the levels of H3K4 monomethylation remained
unchanged. Treatment with MTA inhibited IL-1-induced H3K4 methylation
as well as IL-1-induced iNOS and COX-2 expression.
Conclusions: These results indicate that H3K4 methylation contributes
to IL-1-induced iNOS and COX-2 expression and suggest that this path-
way could be a potential target for pharmacological intervention in the
treatment of OA.
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SULFORAPHANE REPRESSES MATRIX-DEGRADING PROTEASES AND
PROTECTS CARTILAGE FROM DESTRUCTION IN VITRO
R.K. Davidson1, K.L. Culley1, R. Norton1, M. O’Connell1, A. Cooper2,
S.T. Donell2, Y. Bao1, I.M. Clark1
1Univ. of East Anglia, Norwich, United Kingdom; 2Norfolk and Norwich Univ.
Hosp., Norwich, United Kingdom
Purpose: Sulforaphane (SFN) is a naturally occurring isothiocyanate found
at high levels in cruciferous vegetables (particularly broccoli) and is part of
the habitual human diet. SFN is reported to be a histone deacetylase (HDAC)
inhibitor and we and others have described classical HDAC inhibitors as
chondroprotective. Further, SFN has also been shown to function via ac-
tivation of the Nrf2 transcription factor. Hence, we investigated SFN as a
chondroprotective agent whilst examining HDAC inhibition and induction
of the Nrf2 transcription factor as two potential mechanisms of action in
chondrocytes.
Methods: Primary human articular chondrocytes (HACs) and the SW1353
chondrosarcoma cell line were grown in monolayer culture and treated
with interleukin-1 (IL-1) and oncostatin M (OSM) in the presence or ab-
sence of SFN. Histone deacetylase activity was detected by western blotting
for histone acetylation. Inhibition of cytokine-induced metalloproteinase
expression was measured using quantitative RT-PCR and western blot-
ting. Bovine nasal cartilage and human articular cartilage explant models
were used to measure cartilage destruction. siRNA knockdown was used
to examine the function of Nrf2 in the regulation of metalloproteinase
expression in chondrocytes.
Results: SFN at 2.5-30 μM did not affect histone H3 or H4 acetylation in
primary HACs or the SW1353 cell line. SFN at 2.5-10 μM dose-dependently
attenuated cytokine-induced MMP1, MMP3, MMP13 expression in HACs
and SW1353 cell line. ADAMTS5 and ADAMTS4 cytokine-induced expression
was repressed by the same SFN treatment in HACs. Cytokine-induced
cartilage destruction in vitro was abrogated by SFN in both bovine and
human cartilage explant models. The Nrf2 pathway was active in chondro-
cytes, and activated by SFN treatment, but did not mediate repression of
metalloproteinase expression by SFN.
Conclusions: SFN can dose-dependently attenuate the induction of metal-
loproteinase expression and protect against cartilage destruction in vitro.
These actions are not mediated by the inhibition of histone deacetylases
or the induction of the Nrf2 transcription factor. SFN is a potential
chondroprotective agent.
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CCAAT ENHANCER BINDING PROTEIN MEDIATES CATABOLIC PROCESSES
OF ARTHRITIS CARTILAGE
K. Okazaki, H. Tsushima, M. Hayashida, Y. Iwamoto
Kyushu Univ., Fukuoka, Japan
Purpose: Matrix metalloproteinases (MMPs) are considered to be major
proteases which degrade cartilage matrix structures in osteoarthritis (OA)
cartilage. The expressions of MMPs are regulated by many factors such
as mechanical stresses, oxidants, matrix fragments, phenotypic change of
chondrocytes and inﬂammation. CCAAT/enhancer-binding protein (C/EBP)
is a family of basic leusine zipper transcriptional factors which mediates
many inﬂammatory signals. In fact, C/EBPβ is expressed in tissues of OA as
well as rheumatoid arthritis (RA). The purpose of this study is to investigate
the involvement of C/EBP in the expression of catabolic enzymes in arthritis
cartilage.
Methods: Immunohistochemistry: To examine the expression pattern of
C/EBPβ and MMP-3 and 13 in OA cartilage, immunohistochemical staining
was performed in the articular cartilage obtained from patients with OA at
the time of total knee arthroplasty.
Cell culture: C-28/I2 immortalized human chondrocytes and SW982 human
synovial sarcoma cells were cultured.
Gene overexpression: Transient transfection was performed to cell lines
using adenovirus expression vectors for C/EBPβ
Gene knockdown: C/EBPβ Silencer Pre-designed siRNA.
Promoter assay: We constructed the pGL4-basic vector containing the 5’-
ﬂanking region of the human MMP-3 and MMP-13 promoter. Promoter
constructs and an C/EBPβ-LAP expression vector were cotransfected into
C-28/I2.
ChromatinImmunoprecipitation (ChIP) Assay: The C-28/I2 cells were treated
with TNF-α (2ng/ml). For immunoprecipitation, anti-C/EBPβ antibody or
normal rabbit IgG was used.
Results: Immunohistochemistry showed that C/EBPβ, MMP-3 and -13 were
co-expressed in the degenerative cartilage. Western blot analysis revealed
the expression of C/EBPβ in both cell lines after treatment with IL-1β. In
cells transfected with adenovirus expression vector for C/EBPβ, MMP-1, -3,
13 and ADAMTS-5 expression were signiﬁcantly increased (Fig. 1). C/EBPβ
knockdown with SiRNA dramatically reduced the MMP-3 expression in
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